Reckitt Benckiser Newswire

Reckitt Benckiser Newswire

Comprehensive Real-Time News Feed for Reckitt Benckiser.

Results 1 - 20 of 3,160 in Reckitt Benckiser

  1. Reckitt Benckiser (RB) PT Set at GBX 7,020 by Goldman SachsRead the original story w/Photo

    13 hrs ago | IntersportsWire

    ... RB. Liberum Capital reaffirmed a "buy" rating and set a GBX 8,000 ($114.55) price objective on shares of Reckitt Benckiser in a research report on Monday, February 19th. Societe Generale set a GBX 6,500 ($93.07) price objective on Reckitt Benckiser ...

    Comment?

  2. Reckitt Benckiser (RB) Rating Reiterated by Liberum CapitalRead the original story w/Photo

    Yesterday | Daily Political

    ... analysts also recently issued reports on the company. Credit Suisse Group lowered their price objective on Reckitt Benckiser from GBX 6,300 ($90.21) to GBX 5,550 ($79.47) and set an "underperform" rating for the company in a research report on ...

    Comment?

  3. Reckitt Benckiser (RB) Given New GBX 7,300 Price Target at JPMorgan ChaseRead the original story w/Photo

    Yesterday | AmericanBankingNews.com

    ... company. Deutsche Bank restated a "buy" rating and set a GBX 8,500 ($121.71) price objective on shares of Reckitt Benckiser in a report on Monday, June 19th. Macquarie restated an "outperform" rating and set a GBX 9,000 ($128.87) price objective on ...

    Comment?

  4. UPDATE 2-European shares mark fourth week of gains; Ericsson shinesRead the original story w/Photo

    Friday | Reuters

    ... exposed FTSE .FTSE index outperform with a gain of 0.5 percent. The index weathered a 2.8 percent fall in Reckitt Benckiser ( ) increased its offer for the rare-disease drugs specialist to 47 pounds-a-share. Shire has rejected Takeda's previous ...

    Comment?

  5. UPDATE 1-FTSE 100 posts fourth straight week of gains while Reckitt, Shire fallRead the original story w/Photo

    Friday | Reuters

    Weaker sterling helped Britain's FTSE 100 outperform European markets on Friday, while consumer giant Reckitt Benckiser tumbled after disappointing results and Shire declined as Allergan pulled out of the running to acquire the company. The leading UK stock index closed up 0.54 percent at 7368.17 points, posting a fourth straight week of gains with a 1.4 percent rise, its longest winning streak since mid-January.

    Comment?

  6. Sector movers: Building materials lead gainsRead the original story w/Photo

    Friday | Live Charts

    ... the final throes, while household goods & home construction sector was lower at first-quarter results from Reckitt Benckiser disappointed and housebuilder Countryside Properties was hit by US hedge fund Oaktree Capital selling its entire 8% stake in ...

    Comment?

  7. TransUnion to Buy Callcredit, Novartis Profit Surges on Cancer DrugRead the original story

    Friday | Ticker

    ... sales soared 9% but reported cautious outlook. Novartis profit surged after higher sales growth. Reckitt Benckiser sales soared on strong growth in North America. In London trading, FTSE 100 index rose 24.20 or 0.3% to 7,353.14 and in Frankfurt the ...

    Comment?

  8. Reckitt Benckiser (RB) Given "Buy" Rating at Berenberg BankRead the original story w/Photo

    Friday | AmericanBankingNews.com

    ... company. Numis Securities reissued an "add" rating and set a GBX 8,000 ($114.55) target price on shares of Reckitt Benckiser in a research note on Monday, April 24th. Kepler Capital Markets reissued a "buy" rating and set a GBX 8,100 ($115.98) ...

    Comment?

  9. Reckitt Benckiser (RB) Given a GBX 7,020 Price Target by Goldman Sachs AnalystsRead the original story w/Photo

    Friday | AmericanBankingNews.com

    ... on RB. Deutsche Bank reiterated a "buy" rating and issued a GBX 8,250 ($118.13) target price on shares of Reckitt Benckiser in a research note on Tuesday, January 23rd. Barclays set a GBX 6,700 ($95.93) target price on Reckitt Benckiser and gave the ...

    Comment?

  10. Reckitt Benckiser (RB) Receives "Buy" Rating from Whitman HowardRead the original story w/Photo

    Friday | AmericanBankingNews.com

    ... the stock. Jefferies Group reissued a "buy" rating and set a GBX 8,000 ($114.55) target price on shares of Reckitt Benckiser in a research report on Friday, April 28th. JPMorgan Chase raised their price target on Reckitt Benckiser from GBX 6,750 ...

    Comment?

  11. Reckitt Benckiser hit by rivals' flu medicines as sales disappointRead the original story w/Photo

    Friday | This Is London

    Shares in Reckitt Benckiser caught a cold on Friday after the consumer goods giant warned of more competition in the flu medicines market. The FTSE 100 firm said its Mucinex flu treatment was hit by the return of some private-label rivals in the first quarter, and sales growth would be weaker than expected.

    Comment?

  12. FTSE 100 set for fourth straight week of gainsRead the original story w/Photo

    Friday | Business World

    Weaker sterling helped Britain's FTSE 100 outperform European markets on Friday, while consumer giant Reckitt Benckiser tumbled after disappointing results and Shire declined as Allergan pulled out of the running to acquire the company. The leading UK stock index was set for its fourth straight week of gains, its longest winning streak since mid-January.

    Comment?

  13. Unloved and undervalued? Why the FTSE 100 may be a good buy at the momentRead the original story w/Photo

    Friday | This Is Money

    My husband's ex-wife demanded half his pension, will their son inherit it now she's dead - or will he get to keep it? Cancer and your finances: The extra help you probably don't know about - from buying wigs to getting student loans written off A third of landlords with just one buy-to-let are considering selling up - but bigger landlords want to invest more FTSE LIVE: UK shares push higher as sterling slips after Mark Carney backtracks on May rate rise; Reckitt Benckiser boosted by demand for cold and flu treatments Could this simple trick shave hundreds off your car insurance? How new drivers could save up to A 800 a year Five Ferraris you've probably never heard of that are tipped to sell for a stunning A 12MILLION at auction Entrepreneur launches a website where you can raffle your home instead of selling it - and the first on offer is a trendy A 650k London flat at A 5 a ticket 'We ... (more)

    Comment?

  14. Headache for Nurofen owner Reckitt Benckiser as poor sales disappoint analystsRead the original story w/Photo

    Friday | Independent.ie

    Durex owner Reckitt Benckiser disappointed City analysts with its sales performance in the first quarter, sending its shares down 6pc in morning trading on Friday. Durex owner Reckitt Benckiser disappointed City analysts with its sales performance in the first quarter, sending its shares down 6pc in morning trading on Friday.

    Comment?

  15. UPDATE 1-European shares set for fourth week of gains; Ericsson shinesRead the original story w/Photo

    Friday | Reuters

    ... exposed FTSE .FTSE index outperform with a gain of 0.4 percent and weather a 6.4 percent fall in Reckitt Benckiser ( Still in earnings, Telia was an outstanding gainer, up 8.3 percent, after the Nordics telecoms group announced a welcome share ...

    Comment?

  16. UPDATE 1-Reckitt misses Q1 estimates on Scholl missteps, weak pricingRead the original story w/Photo

    Friday | Reuters

    Reckitt Benckiser lagged other consumer good makers in the first quarter as further falls in Scholl footcare and lower prices hit the British company's sales growth. Bernstein analysts said Reckitt's like-for-like sales growth was "bottom of class" of the five European food and packaged goods companies that have reported quarterly sales so far, and it shares fell 5 percent on Friday to their lowest level since August 2015.

    Comment?

  17. Government plan to professionalise buy-to-let seems to be workingRead the original story w/Photo

    Friday | This Is Money

    ... a movie FTSE LIVE: UK shares push higher as sterling slips after Mark Carney backtracks on May rate rise; Reckitt Benckiser boosted by demand for cold and flu treatments Drug firm Shire in A 42bn takeover tug-of-war: Rare disease expert set to be at ...

    Comment?

  18. Reckitt Benckiser's first-quarter growth disappointsRead the original story w/Photo

    Friday | Live Charts

    Durex, Dettol and Strepsils maker Reckitt Benckiser reported sales growth continued in the first quarter where it left off last year, but confirmed negative pricing in its home and hygiene division. Net revenue of A 3.1bn in the first three months of the year was up 23% on last year, thanks to the acquisition of infant formula and child nutrition business Mead Johnson Nutrition.

    Comment?

  19. London open: Stocks rise as pound falls back on Carney commentsRead the original story w/Photo

    Friday | Live Charts

    ... a day after Japan's Takeda said the company had rejected a A 42.4bn takeover offer. Durex and Dettol maker Reckitt Benckiser was under the cosh as like-for-like sales for the first quarter fell short of estimates, while housebuilder Countryside ...

    Comment?

  20. Five Ferraris you've never heard of tipped to sell for A 12m at Sotheby'sRead the original story w/Photo

    Friday | This Is Money

    My husband's ex-wife demanded half his pension, will their son inherit it now she's dead - or will he get to keep it? Cancer and your finances: The extra help you probably don't know about - from buying wigs to getting student loans written off Could this simple trick shave hundreds off your car insurance? How new drivers could save up to 800 a year A third of landlords with just one buy-to-let are considering selling up - but bigger landlords want to invest more Entrepreneur launches a website where you can raffle your home instead of selling it - and the first on offer is a trendy 650k London flat at 5 a ticket 'We bought a new-build in a city so why is our broadband so slow?' Couple left battling an internet connection that can take a day to download a movie FTSE LIVE: UK shares push higher as sterling slips after Mark Carney backtracks on May rate rise; Reckitt Benckiser boosted by ... (more)

    Comment?